Atossa Therapeutics
ATOS
#9237
Rank
S$0.13 B
Marketcap
S$1.04
Share price
5.24%
Change (1 day)
-36.70%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -S$37.65 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$33.06 Million, an increase over its 2023 earnings that were of -S$39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$37.65 Million13.9%
2024 -S$33.06 Million-15.25%
2023 -S$39 Million11.62%
2022 -S$34.94 Million30.84%
2021 -S$26.71 Million15.58%
2020 -S$23.11 Million3.41%
2019 -S$22.35 Million51.16%
2018 -S$14.78 Million40.41%
2017 -S$10.53 Million27.54%
2016 -S$8.26 Million-47.49%
2015 -S$15.72 Million-17.25%
2014 -S$19 Million35.91%
2013 -S$13.98 Million112.3%
2012 -S$6.59 Million46.53%
2011 -S$4.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.98 B-112,907.30%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$1.72 B-4,742.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.66 B-4,581.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-S$10.17 Million-72.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
S$54.01 M-245.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-S$0.15 Billion 280.29%๐Ÿ‡บ๐Ÿ‡ธ USA